Nirmatrelvir/Ritonavir for hemodialysis patients with COVID-19

• Main Authors: Jiayue Lu (Author), Hong Cai (Author), Yujun Hao (Author), Zhang Lin (Author), Shang Liu (Author), Yaping Zhan (Author), Li Ding (Author), Meilan Huang (Author), Zhenyuan Li (Author), Lan Xu (Author), Xiujuan Yan (Author), Li Yang (Author), He Zhang (Author), Wei Zhang (Author), Li Zhao (Author), Junli Zhao (Author), Ting Wang (Author), Leyi Gu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Hemodialysis patients have a high risk of severe/critical COVID-19 and related high mortality, but nirmatrelvir/ritonavir is not recommended for hemodialysis patients with COVID-19 infection because of lack of evidence of safety.Objectives: Our study aims to evaluate the minimum plasma c...